본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Nutraceuticals and food v.7 no.2, 2002년, pp.222 - 229   피인용횟수: 2

New Technologies For Health Foods and Nutraceuticals

Yalpani, Manssur   (CarboMer, Inc., Westborugh  );
  • 초록

    초록이 없습니다.

  • 참고문헌 (49)

    1. Yalpani M. 1997. New Technologies for Healthy Foods & Nutraceuticals. Yalpani M, ed. ATL press, Mount Prospect. p 1-10 
    2. Anon. 2000. Nutr Bus J 
    3. Challener C. 2000. Specialty dietary supplement ingredients are the hot spot. Chem Market Rep 258 (Sep. 25): pFR8 
    4. Anon. 1998. Nutr Bus J 
    5. Mettienen TA, Gylling H. 1997. In New Technologies for Healthy Foods & Nutraceuticals. Yalpani M, ed. ATL press, Mount Prospect. p 53-70 
    6. Wilhelm C. 2000. Leveling demand for dietary supplements. Chem Market Rep 257 (May 29): pFR8 
    7. Jiang Q, Elson-Schwab I, Courtmanche C, Ames BN. 2000. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci 10: 11494- 11499 
    8. Khor HT, Chieng DY. 1997. Effect of squalene, tocotrienols and tocopherol supplementations in the diet on serum and liver lipids in the hamster. Nutr Res 17: 475-483 
    9. Goh SH, Hew NF, Norhanom AW, Yadav M. 1997. Inhibition of tumour promotion by various palm-oil tocotrienols. Int J Cancer 57: 529-531 
    10. Yalpani M. 1997. In New Technologies for Healthy Foods & Nutraceuticals. Yalpani M, ed. ATL press, Mount Prospect, p 53-70 
    11. Gershwin ME, German JB. 2000. Nutr Immunol. Humana Press, Totowa NJ 
    12. Riggi SJ, Di Luzzio NR. 1961. Am J Physiol 200: 297 
    13. Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME. 1999. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 221: 281-293 
    14. Hayakawa K, Mitsuhashi N, Saito Y, Takahashi M, Katano S, Shiojima K, Furuta M, Niibe H. 1993. Anticancer Res 13: 174-409 
    15. Goldman RC. 1996. Ann Rep Medicinal Chem 30: 129-138 
    16. Ink S, Mathews R. 1997. In New Technologies for Healthy Foods & Nutraceuticals. Yalpani M, ed. ATL Press, Mount Prospect. p 195-235 
    17. Mizuno M, Minato K, Ito H, Kawade M, Terai H, Tsuchida H. 1999. Biochem Mol Bio Int 47: 707-714 
    18. Popvitch B. 2000. Business Communication Co. Chem Market Rep 258 (Sep. 25) 
    19. Mascarenhas MR, Tershakovec AM, Stettler N. 1999. Nutrition interventions in childhood for the prevention of chronic disease in adulthood. Curr Opin Pediatr 11: 598-604 
    20. Luke RB. 2001 (June). Supplements for joint health. Nutraceuticals World 
    21. Groop PH. 1997. In New Technologies for Healthy Foods & Nutraceuticals. Yalpani M, ed. ATL Press, Mount Prospect. p 179-194 
    22. Khan AR, Khan GY, Mitchell A, Quadeer MA. 1981. Effect of guar gum on blood lipids. Am J Clin Nutr 39: 2446-2449 
    23. Wu J, Peng SS. 1997. Comparison of hypolipidemic effect of refined konjac meal with several common dietary fibers and their mechanisms of action. Biomed Environ Sci 10: 27-37 
    24. Emako M, Tomohisa T, Katsuyoshi N. 1998. Effects of glucose, mannose and konjac glucomannan on the gel-sol transition in gellan gum aqueous solutions by rheology and DSC. Polym Gels Networks 6: 273-290 
    25. Levrat-Verny MA, Behr S, Mustad V, Remesy, Demigne C. 2000. Low levels of viscous hydrocolloids lower plas-ma cholesterol in rats primarily by impairing cholesterol absorption. J Nutr 130: 243-248 
    26. Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P, Collins MW.1994. Oat beta-glucan reduces blood cholesterol concentration in hypercholes-terolemic subjects. Eur J Clin Nutr 48: 465-474 
    27. Braaten JT, Scott FW, Wood PJ, Riedel KD, Wolynetz MS, Brule D, Collins MW. 1994. High beta-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetis. Diab Med 11: 312-318 
    28. Madar Z, Abel R, Samish S, Arad J. 1988. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur J Clin Nutr 42: 51-54 
    29. Gordon DT, Topp K, Shi YC, Zallie J, Jeffcoat R. 1997. In New Technologies for Healthy Foods & Nutraceuticals. Yalpani M, ed. ATL Press, Mount Prospect. p 157-178 
    30. Haralampu SG. 2000. Resistant starch a review of the phys-ical properties and biological impact of RS3. Carbohyd Polym 41: 285-292 
    31. Ghannam N, Kingston M, Al-Meshaal IA, Tariq M, Parman NS, Woodhouse N. 1986. The antidiabetic activity of aloes preliminary clinical and experimental observations. Hormone Res 24: 288-294 
    32. Morellei V, Zoorob RJ. 2000. Alternative therapies: part 1, depression, diabetes, obesity. Am Family Physician 62: 1051-1060 
    33. Parkash A, Ng TB, Tso WW. 2002. Putrification and char-acterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds. J Peptide Res 59: 197-202 
    34. Leatherdale BA, Panesar R, Singh G, Atkins TW, Bailey CJ, Bigwell AH. 1981. Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J 282: 1823-24 
    35. Welihinda J, Karunanaya E, Sheriff MHB, Jayasinghe K. 1986. J Ethnopharm 17: 277-282 
    36. Chandrasekar B, Mukherjee B, Mukherjee SK. 1989. Indian J Med Res 90: 300-305 
    37. Parakash AO, Mathur S, Mathur R. 1986. Effect of feed-ing Gymnema sylvestre leaves on blood glucose in beryl-lium nitrate treated rats. J Ethnopharm 18: 143-146 
    38. Shapiro K, Gong WC. 2002. Natural products used for dia-betes. J Am Pharm Asso 42: 217-226 
    39. Frati-Munari AC, Fernandez-Harp JA, de la Riva H, Ariza- Andraca R, del Carmen Torres M. 1983. Effects of nopal (Opuntia sp.) on serum lipids, glycemia and body weight. Arch Invest Med 14: 117-125 
    40. Jarvus L. 2001. Lutein buoys supplements market with eye health applications. Chem Market Rep 260 (July 16): 10 
    41. Miki W. 1992. Recent advances in carotenoid studies-metabolisms and bioactivities. J Nutr Sci Vitaminol 38: 469-472 
    42. de la Monte SM, Sohn YK, Wands JR. 1997. Correlates of p53- and Fas (CD95) mediated apoptosis in Alzheimers disease. J Neurol Sci 152: 73-83 
    43. de la Monte SM, Sohn YK, Ganju N, Wands JR. 1998. P53- and CD95-associates apoptosis in neurodegenerative diseases. Lab Invest 78: 401-411 
    44. Parkinson Study Group. 1993. N Eng J Med. 328: 176-183 
    45. Kontush A, Mann U, Arlt S, Ujeyl A, Luhrs C, Muller- Tomsen T, Beisiegel U. 2001. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic Biol Med 31: 345-354 
    46. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E. 2001. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30: 235-241 
    47. Franchi F. 1998. Arch Geront Geriatrics 6: 207-214 
    48. McDowell I. 2001. Alzheimers disease: insights from epidemiology. Aging 13: 143-162 
    49. Yalpani M. 2002. US Pat. Application 
  • 이 논문을 인용한 문헌 (2)

    1. 2009. "" Fisheries and aquatic sciences, 12(4): 258~264     
    2. Kim, Young-Jun ; Cho, Suk-Hyung 2009. "Preparation of High Purity Chondroitin Sulfate" 한국산학기술학회논문지 = Journal of the Korea Academia-Industrial cooperation Society, 10(4): 865~871     

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역


  • NDSL :
  • 한국식품영양과학회 : 저널

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기